Pharma Stocks Outlook for the week – 12 to 16.10.2015
(Expected
to trade narrow range)
Stocks
of several pharmaceutical stocks are expected to trade in a narrow range next
week, the Street is likely to witness buying in counters of Sun Pharmaceutical
Industries and Aurobindo Pharma on expectations of good Jul-Sep earnings and a
significant product launch.
Positive
moementum of Sun Pharma after the company announced that its arm Ranbaxy
Pharmaceuticals Inc, along with its partners Cipher Pharmaceuticals Inc and
Galephar Pharmaceutical Research Inc, entered into a settlement agreement with
Actavis that dismisses the patent litigation suit relating to Actavis
abbreviated new drug application for generic of Absorica capsules.
Hyderabad-based
Aurobindo Pharma yesterday said that it has received approval from the US Food
and Drug Administration for generic of Otsuka Pharmaceutical Co Ltd's Abilify
tablets in six strengths, market size of which is estimated at $7.3 bln for the
12-months period ending August. Aurobindo Pharma's stocks will continue with
the upward momentum gained after the news.
